Table 3.
For the Indian and multinational trials in Phase 3, the top cities that accounted for 50% or more of the trials in a given zone.
Zone | Top cities for 163 Indian trials | Top cities for 28 multinational trials |
---|---|---|
Central | Lucknow (48.7%), Kanpur Nagar (20.4%) | Lucknow (31.8%), Indore (22.7%) |
Eastern | Kolkata (57.9%) | Kolkata (64.5%) |
North-Eastern | Kamrup (83.3%) | Kamrup (50%), Jorhat (50%) |
Northern | Delhi (37.9%), Jaipur (31.3%) | Delhi (48.1%), Jaipur (19.2%) |
Southern | Hyderabad (21.3%), Bangalore (21.3%), Srikakulam (8.3%) | Hyderabad (19.7%), Bangalore (15.9%), Chennai (10.6%), Coimbatore (6.8%) |
Western | Ahmedabad (19.9%), Pune (16.6%), Mumbai (15.5%) | Pune (25.5%), Ahmedabad (19.1%), Mumbai (18.2%) |